Projection of top 2018 pharma and biotech launches by revenue 2022

This statistic depicts the top biotech and conventional pharmaceutical product launches globally in 2018 and their projected revenues for 2022. AbbVie's probably in 2018 to be-launched product Elagolix is expected to garner some 1.2 billion U.S. dollars in 2022.

Top biotech and pharma product launches in 2018 and revenue forecast for 2022

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2017

Region

Worldwide

Survey time period

as of November 2017

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Clinical trials"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.